Swiss National Bank Collegium Pharmaceutical, Inc Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Swiss National Bank holds 63,900 shares of COLL stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,900
Previous 64,400 0.78%
Holding current value
$1.83 Million
Previous $2.07 Million 19.1%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$31.4 - $39.07 $15,700 - $19,535
-500 Reduced 0.78%
63,900 $2.47 Million
Q1 2024

May 07, 2024
SELL
$31.23 - $40.91 $128,043 - $167,731
-4,100 Reduced 5.99%
64,400 $2.5 Million
Q4 2023

Feb 06, 2024
SELL
$21.16 - $30.8 $160,816 - $234,080
-7,600 Reduced 9.99%
68,500 $2.11 Million
Q3 2023

Nov 08, 2023
BUY
$21.23 - $24.28 $16,984 - $19,424
800 Added 1.06%
76,100 $1.7 Million
Q2 2023

Aug 09, 2023
BUY
$21.06 - $24.0 $134,784 - $153,600
6,400 Added 9.29%
75,300 $1.62 Million
Q1 2023

May 10, 2023
SELL
$23.0 - $29.88 $213,900 - $277,884
-9,300 Reduced 11.89%
68,900 $1.65 Million
Q4 2022

Feb 08, 2023
BUY
$16.14 - $23.55 $12,912 - $18,840
800 Added 1.03%
78,200 $1.81 Million
Q2 2022

Aug 09, 2022
BUY
$14.22 - $20.88 $54,036 - $79,344
3,800 Added 5.16%
77,400 $1.37 Million
Q1 2022

May 09, 2022
BUY
$17.2 - $22.5 $60,200 - $78,750
3,500 Added 4.99%
73,600 $1.5 Million
Q3 2021

Nov 08, 2021
BUY
$17.75 - $25.39 $21,300 - $30,468
1,200 Added 1.74%
70,100 $1.38 Million
Q2 2021

Aug 06, 2021
SELL
$21.74 - $25.28 $47,828 - $55,616
-2,200 Reduced 3.09%
68,900 $1.63 Million
Q1 2021

May 07, 2021
BUY
$19.25 - $26.1 $21,175 - $28,710
1,100 Added 1.57%
71,100 $1.69 Million
Q3 2020

Nov 09, 2020
BUY
$15.78 - $20.82 $42,606 - $56,214
2,700 Added 4.01%
70,000 $1.46 Million
Q2 2020

Aug 05, 2020
BUY
$15.49 - $23.51 $236,997 - $359,703
15,300 Added 29.42%
67,300 $1.18 Million
Q1 2020

May 08, 2020
BUY
$13.89 - $25.45 $11,112 - $20,360
800 Added 1.56%
52,000 $849,000
Q4 2019

Feb 06, 2020
BUY
$10.7 - $22.24 $17,120 - $35,584
1,600 Added 3.23%
51,200 $1.05 Million
Q2 2019

Aug 02, 2019
BUY
$10.62 - $16.59 $90,270 - $141,015
8,500 Added 20.68%
49,600 $652,000
Q4 2018

Feb 13, 2019
BUY
$14.78 - $19.68 $45,818 - $61,008
3,100 Added 8.16%
41,100 $706,000
Q1 2018

May 04, 2018
BUY
$18.15 - $29.21 $139,755 - $224,917
7,700 Added 25.41%
38,000 $971,000
Q3 2017

Nov 03, 2017
BUY
$9.15 - $11.97 $277,245 - $362,691
30,300
30,300 $318,000

Others Institutions Holding COLL

# of Institutions
255
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $977M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email